News

The generic equivalent of IPR Pharmaceuticals’ Zomig tablets is indicated for the acute treatment of migraine with or without aura in adults. Mylan commenced the product shipment. The

The possibility of the agreement includes two phases such as a facility preparation and readiness phase and a clinical trial supply phase. Nordion medical isotopes general manager Tom

The collaboration aims to optimize productivity in the design and execution of studies while focusing on quality, speed and efficiency. Merck Serono global development and medical executive vice

With the agreement, Hitachi High-Technologies will gain exclusive rights to market Nanosphere products in Japan. The two companies also plan to collaborate on assay and platform development. Hitachi

This is the second agreement with QIAGEN within nine months; the first licence agreement was signed for the amplification buffer technology developed by the team led by renowned

The new software widens the functionality of Definiens’ current product portfolio and offers a high quality control advantage, with up to a two-fold reduction in hands on time

Nexavar (sorafenib) tablet is an anticancer medicine for the treatment of patients with unresectable HCC. Stivarga is an inhibitor of multiple kinases involved in normal cellular functions and

Xofigo is the first alpha particle-emitting radioactive therapeutic agent that has showed improvement in overall survival (OS) and delay in time to first symptomatic skeletal event (SSE) compared

The enrolment of the first patient in Phase 1b/2 INvestigation of anti-Notch Antibody therapy with Cisplatin and etoposide in small cell Lung carcinoma Efficacy and safety (PINNACLE) trial